MetLife (NYSE:MET – Get Free Report) announced its quarterly earnings results on Wednesday. The financial services provider reported $2.42 earnings per share for the quarter, beating the consensus estimate of $2.25 by $0.17, Zacks reports. The firm had revenue of $19.68 billion for the quarter, compared to analysts’ expectations of $19.49 billion. MetLife had a net margin of 4.38% and a return on equity of 21.81%.
MetLife Trading Up 0.4%
MET traded up $0.33 on Wednesday, hitting $80.23. The company had a trading volume of 3,283,035 shares, compared to its average volume of 3,792,539. The firm has a market cap of $52.31 billion, a P/E ratio of 17.07, a PEG ratio of 0.70 and a beta of 0.78. MetLife has a 1 year low of $67.33 and a 1 year high of $83.85. The company’s fifty day moving average price is $73.15 and its 200 day moving average price is $76.51. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52.
MetLife Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 9th. Investors of record on Tuesday, May 12th will be issued a $0.5925 dividend. This is an increase from MetLife’s previous quarterly dividend of $0.57. The ex-dividend date is Tuesday, May 12th. This represents a $2.37 annualized dividend and a yield of 3.0%. MetLife’s payout ratio is presently 48.30%.
Institutional Trading of MetLife
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Weiss Ratings raised shares of MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday. Morgan Stanley lowered their price target on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. UBS Group boosted their price target on shares of MetLife from $98.00 to $102.00 and gave the company a “buy” rating in a research report on Thursday, April 9th. Wall Street Zen raised shares of MetLife from a “hold” rating to a “buy” rating in a research report on Saturday, April 11th. Finally, Evercore set a $96.00 price target on shares of MetLife in a research report on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $93.38.
Read Our Latest Report on MetLife
About MetLife
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Read More
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
